Established in 2004, CIDP (Centre International de Développement Pharmaceutique) is an international Contract Research Organisation (CRO) that carries out high R&D activities for pharmaceutical, medical device, nutraceutical and cosmetic industries.
At CIDP Mauritius, we offer the ideal setting for conducting Phase 1 clinical trials in dermatology.
Our state-of-the-art facility is equipped with cutting-edge technology, including VISIA CR, Spectrophotometer, Fotofinder, Colorface, moisturemeter, and glossymeter. Our team of highly experienced dermatologists and clinical trial specialists is dedicated to ensuring high-quality and ethical clinical trials.
𝗞𝗲𝘆 𝗔𝗱𝘃𝗮𝗻𝘁𝗮𝗴𝗲𝘀 𝗼𝗳 𝗖𝗜𝗗𝗣 𝗠𝗮𝘂𝗿𝗶𝘁𝗶𝘂𝘀:
☑️Advanced Technology: Equipped with the latest tools to deliver precise and reliable results.
☑️Emergency Care:
- Equipped with Emergency trolley, defibrillator, resuscitation kit, patient life monitor, oxygen concentrator.
- In-house doctors trained in life-support skills.
☑️Expert Team: Skilled professionals with extensive experience in dermatology and clinical trials.
☑️Favourable Regulatory Environment: Mauritius offers a swift approval timeline of only 30 days and a stable political system.
☑️Diverse Population: Mauritius’ multicultural population provides an excellent demographic for testing the efficacy and safety of dermatological treatments.
☑️Proven Track Record: CIDP has a history of successful collaborations with numerous pharmaceutical companies, conducting early phase trials for conditions such as acne, eczema, psoriasis, melasma, vitiligo, atopic dermatitis, and seborrheic dermatitis. Our findings have been published in top-tier scientific journals, showcasing our commitment to advancing dermatological research.
For pharmaceutical companies looking to test new dermatological treatments, CIDP Mauritius is the perfect partner!
Discover more about our
services and how we can support your clinical trial needs. info@cidp-cro.com
